Therapeutic potential of targeting inflammation

被引：2
|
作者：
Hamilton, John A. [1 ]
机构：
[1] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia
来源：
INFLAMMATION RESEARCH | 2013年 / 62卷 / 07期
关键词：
Rheumatoid Arthritis; Periodontitis; Inflammation Research; Pulmonary Alveolar Proteinosis; Industrial Researcher;
D O I：
10.1007/s00011-013-0614-3
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：653 / 657
页数：5
相关论文
共 50 条
  • [21] Inflammation in prostate cancer progression and therapeutic targeting
    Stark, Timothy
    Livas, Lydia
    Kyprianou, Natasha
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2015, 4 (04) : 455 - 463
  • [22] Recent advances in therapeutic targeting of inflammation in atherosclerosis
    Hedin, Ulf
    Matic, Ljubica Perisic
    JOURNAL OF VASCULAR SURGERY, 2019, 69 (03) : 944 - 951
  • [23] The therapeutic value of targeting inflammation in gastrointestinal cancers
    Sun, Beicheng
    Karin, Michael
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (07) : 349 - 357
  • [24] Regulation of Inflammation, Its Resolution and Therapeutic Targeting
    Uguccioni, Mariagrazia
    Teixeira, Mauro Martins
    Locati, Massimo
    Mantovani, Alberto
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [25] Therapeutic Potential of Targeting the Oxytocinergic System
    Romano, Adele
    Provensi, Gustavo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [26] Therapeutic potential of targeting drug in pemphigus
    Abulikemu, K.
    Liang, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S24 - S24
  • [27] Therapeutic potential of targeting the cell cycle
    Webster, KR
    CHEMICAL RESEARCH IN TOXICOLOGY, 2000, 13 (10) : 940 - 943
  • [28] Therapeutic Potential of Targeting the Ghrelin Pathway
    Collden, Gustav
    Tschoep, Matthias H.
    Mueller, Timo D.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (04)
  • [29] Therapeutic Potential of Targeting PAK Signaling
    Senapedis, William
    Crochiere, Marsha
    Baloglu, Erkan
    Landesman, Yosef
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (01) : 75 - 88
  • [30] Deregulation and therapeutic potential of targeting IRAK3 as chronic inflammation suppressor in prostate cancer.
    Oseni, Saheed Oluwasina
    Naar, Corey
    Philemy, Magdalah
    Laguer, Genesis Acosta
    Ambrin, Faika
    Metayer, Sharlanda
    Perez, Ariana
    Betty, Javoncia
    Praveen, Preethika
    Hartmann, James
    Pavlovic, Mirjana
    Kumi-Diaka, James
    CANCER RESEARCH, 2021, 81 (13)
12345